News blog
US regulators approve next-generation sequencer for clinical use
The US Food and Drug Administration (FDA) has issued its first approval of a next-generation sequencing platform to be used for clinical diagnosis, the agency announced on 19 November.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells